OPR - Delayed Quote • USD PTCT Jun 2024 10.000 put (PTCT240621P00010000) Follow 1.0000 0.0000 (0.00%) At close: January 11 at 10:31 AM EST Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for PTCT240621P00010000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: PTCT PTC Therapeutics First Quarter 2024 Earnings: Beats Expectations Sector Update: Health Care Stocks Edge Higher Late Afternoon Q1 2024 PTC Therapeutics Inc Earnings Call PTC Therapeutics Inc (PTCT) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ... Compared to Estimates, PTC Therapeutics (PTCT) Q1 Earnings: A Look at Key Metrics PTC Therapeutics Q1 2024 Earnings: A Detailed Financial Review PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher? PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA A Comprehensive Look at Sarepta's Growth and Innovation
